Welcome to our dedicated page for Accenture Plc Ireland SEC filings (Ticker: ACN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Accenture plc (ACN) SEC filings page brings together the company’s official disclosures to the U.S. Securities and Exchange Commission, including annual and quarterly financial reports, proxy materials and current reports on significant events. As a New York Stock Exchange‑listed company incorporated in Ireland, Accenture uses these filings to provide detailed information on its financial performance, governance, strategy and material developments.
Accenture’s Form 8‑K current reports frequently furnish earnings releases for quarterly and annual periods, outlining revenues, operating margin, earnings per share, bookings, free cash flow and other key metrics. These 8‑K filings also describe the company’s use of non‑GAAP measures such as free cash flow, local‑currency growth and adjusted results that exclude specified business optimization costs, along with reconciliations to GAAP figures. Other 8‑K filings disclose leadership and organizational changes, including updates to Accenture’s growth model and senior management roles.
The company’s definitive proxy statement (DEF 14A) provides extensive detail on corporate governance, board structure, director nominees, executive compensation programs, share incentive plans and shareholder proposals. It also discusses Accenture’s strategy to be the reinvention partner of choice for clients, its Reinvention Services structure, and multi‑year trends in revenue growth, margins, earnings and cash returned to shareholders.
Through this page, users can access Accenture’s 10‑K annual reports, 10‑Q quarterly reports, 8‑K current reports, proxy statements and related exhibits as they are filed with the SEC’s EDGAR system. Stock Titan enhances these documents with AI‑powered summaries that highlight the main points of lengthy filings, explain non‑GAAP reconciliations, and surface items such as compensation plans and governance proposals. Investors tracking ACN can use these filings to review historical performance, understand management’s reporting practices and monitor material events affecting the company.
Julie Spellman Sweet, who serves as Chair and CEO and is a director of Accenture plc (ACN), reported a personal purchase of 159 Class A ordinary shares under the company's Voluntary Equity Investment Program on 10/05/2025. The shares were acquired at an average price of $244.56 per share and the transaction brought her total direct holdings to 8,599 shares. The filing identifies the purchase as a standard payroll/voluntary equity plan participation rather than a secondary-market trade. This update discloses an insider buy while maintaining her existing board and executive roles.
Accenture plc (ACN) insider purchase reported. An officer, Manish Sharma, acquired 75 Class A ordinary shares on 10/05/2025 under the Accenture Voluntary Equity Investment Program at a price of $244.56 per share. After the transaction, the reporting person beneficially owned 1,887 shares directly. The Form 4 was signed on 10/06/2025 by an attorney-in-fact.
The filing identifies the reporting person as an officer (Chief Strategy & Services Officer) and indicates this was a routine purchase through the company equity program rather than an open-market trade or derivative exercise.
Accenture plc (ACN) Chief Leadership & HR Officer Katherine Lee Clifford reported a personal purchase of 66 Class A ordinary shares on 10/05/2025 at a price of $244.56 per share under the Accenture Voluntary Equity Investment Program. After the transaction she beneficially owns 4,821 shares, held directly. The Form 4 was signed by an attorney-in-fact on 10/06/2025. The filing notes the purchase was executed through the company program rather than an open-market trade, and it reflects a routine equity-plan contribution by an officer rather than a derivative or disposition.
Melissa A. Burgum, listed as an officer (Chief Accounting Officer), reported a purchase of 78 Class A ordinary shares of Accenture plc (ACN) on 10/05/2025 at a reported price of $244.56 per share. The acquisition was made under Accenture's Voluntary Equity Investment Program and increased her direct beneficial ownership to 9,560 shares. The Form 4 was signed by an attorney-in-fact on 10/06/2025.
The filing records a routine purchase by an executive under a company equity plan; there are no derivative transactions, dispositions, or amendments noted. All details below are taken directly from the Form 4 disclosure.
Insider transaction by Accenture officer: An Accenture officer, Catherine Kiernan Hogan, reported a purchase of $244.56 per share on 10/05/2025 under the Accenture Voluntary Equity Investment Program. The filing shows 87 Class A ordinary shares were acquired and the reporting person now directly beneficially owns 8,756 Class A shares. In addition, 2,048 shares are held indirectly in a family trust. The Form 4 was signed by an attorney-in-fact on 10/06/2025. The disclosure is a routine Section 16 reporting of an employee equity purchase and does not include derivative transactions or other material changes beyond the shares noted.
John F. Walsh, listed as CEO-The Americas at Accenture plc (ACN), reported a purchase of 113 Class A ordinary shares on 10/05/2025 at a price of $244.56 per share under the Accenture Voluntary Equity Investment Program. After the transaction he beneficially owns 16,411 Class A ordinary shares. The Form 4 was signed by an attorney-in-fact on 10/06/2025. The filing records a single non-derivative acquisition and identifies the transaction code and plan basis for the purchase.
Accenture plc furnished a Form 8-K stating it issued a news release on September 25, 2025 announcing financial results for the fourth quarter and full fiscal year ended August 31, 2025. The filing notes the news release is furnished, not filed, and that it includes non-GAAP financial measures such as free cash flow, local-currency percentage changes in revenues and bookings, and adjusted measures that exclude certain business optimization costs recorded in fiscal 2024 and fiscal 2025. The company explains its methods for calculating these measures and states that reconciliations to the most directly comparable GAAP measures are included in the news release. The filing characterizes the non-GAAP information as supplemental to, not a substitute for, GAAP results.
Insider purchase recorded: Melissa A. Burgum, Chief Accounting Officer of Accenture plc (ACN), acquired 75 Class A ordinary shares on 09/05/2025 at a reported price of $254.42 per share, bringing her direct beneficial ownership to 9,482 shares. The purchase was made under Accentures Voluntary Equity Investment Program and reported on a Form 4. The transaction reflects a routine employee/director share purchase rather than a transfer or sale.
Accenture plc (ACN) insider filing: Katherine Lee Clifford, listed as Accenture's Chief Leadership & HR Officer, acquired 52 Class A ordinary shares on 09/05/2025 at a price of $254.42 per share under Accenture's Voluntary Equity Investment Program. After the transaction she is reported to beneficially own 4,755 Class A ordinary shares. The Form 4 was signed on behalf of the reporting person by an attorney-in-fact and dated 09/08/2025. The filing records a routine purchase under the company's equity program.
Julie Spellman Sweet, Chair and CEO of Accenture plc (ACN), purchased 152 Class A ordinary shares on 09/05/2025 at a price of $254.42 per share under Accenture's Voluntary Equity Investment Program. After the transaction she beneficially owns 8,440 shares, held directly. The Form 4 was signed on 09/08/2025 by an attorney-in-fact. The filing records the acquisition as a routine employee/insider purchase from the company program and discloses no derivatives, dispositions, or additional material terms.